Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time

Background and Aims: Long-term data on cell-based therapies, including hematopoietic stem cell infusion in cirrhosis, are sparse and lacking. Methods: Patients with cirrhosis of non-viral etiology received either standard-of-care (n = 23) or autologous CD34+ cell infusion through the hepatic artery...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Mithun, Kulkarni, Anand, Sasikala, Mitnala, Kumar, Pramod, Jaggaiahgari, Shasidhar, Pondugala, Kumar, Jaishetwar, Ganesh, Darisetty, Santosh, Jagtap, Nitin, Gupta, Rajesh, Singh, Jagadeesh Rampal, Fatima, Syeda, Rao, Padaki Nagaraja, Rao, Guduru Venkat, Reddy, Duvurr Nageshwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782109/
https://www.ncbi.nlm.nih.gov/pubmed/33447521
http://dx.doi.org/10.14218/JCTH.2020.00052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782109/
https://www.ncbi.nlm.nih.gov/pubmed/33447521
http://dx.doi.org/10.14218/JCTH.2020.00052

Ejemplares similares